Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb to Report Results for First Quarter 2021 on April 29, 2021
Bristol-Myers Squibb Company (NYSE: BMY) Q1 2021 Earnings Conference
AlphaGraphs
Bristol Myers (BMY) stock gains after Q4 results beat Street view
Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company’s stock gained in the pre-market session soon after the announcement. The pharmaceutical company…
AlphaGraphs
Highlights of Bristol-Myers Squibb Company (NYSE: BMY) Q2 2020 Earnings
Pharmaceutical firm Bristol-Myers Squibb Company (NYSE: BMY) reported second-quarter 2020 financial results on Thursday morning. The results were better than analysts’ expectations. Revenues surged 61%…
Bristol-Myers Squibb Co (NYSE: BMY) Q1 2020 Earnings Call Transcript
Bristol-Myers Squibb Co (BMY) Q1 2020 earnings call dated May. 07, 2020 Corporate Participants: Timothy Power — Vice President, Investor Relations Giovanni Caforio — Chairman of the Board and…
ADVERTISEMENT
AlphaGraphs
Visual Representation of Bristol-Myers Squibb Company (BMY) Q1 2020 earnings
Bristol-Myers Squibb Company (NYSE: BMY) reported first-quarter 2020 financial results before the regular trading hours on Thursday. The results were better than analysts’ expectations. CEO…
Market News
Bristol-Myers Squibb (BMY) slips to a loss in Q4 but beats estimates
Bristol-Myers Squibb Company (NYSE: BMY) slipped to a loss in the fourth quarter of 2019 from a profit last year, due to the amortization of…
Market News
Bristol-Myers Squib (BMY) set to report Q4 earnings – what is in the offing?
After closing the high-value acquisition of Celgene a few months ago, Bristol-Myers Squib (NYSE: BMY) will be publishing its fourth-quarter results on Thursday before the…
Bristol-Myers Squibb (BMY) earnings: Q3 results beat amid strong product sales
Driven by the strong sales of leading products, earnings of Bristol-Myers Squibb (NYSE: BMY) increased in the third quarter and exceeded the market’s projection. Total…
ADVERTISEMENT
Analysis
Bristol-Myers (BMY) Q3 earnings preview: New indications, pipeline to bolster recovery
Bristol-Myers Squibb (NYSE: BMY) will be publishing its September-quarter earnings Thursday before the opening bell. The bio-pharmaceutical company is expected to earn $1.07 per share…